219 related articles for article (PubMed ID: 8821045)
1. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Quack G; Hesselink M; Danysz W; Spanagel R
J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat.
Clement HW; Grote C; Svensson L; Engel J; Zöfel P; Wesemann W
J Neural Transm Suppl; 1995; 46():107-15. PubMed ID: 8821046
[TBL] [Abstract][Full Text] [Related]
3. Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats.
Hesselink MB; De Boer AG; Breimer DD; Danysz W
J Neural Transm (Vienna); 1999; 106(9-10):803-18. PubMed ID: 10599863
[TBL] [Abstract][Full Text] [Related]
4. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
Afanas'ev II; Dvorkina ML; Raevskiĭ KS
Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
[TBL] [Abstract][Full Text] [Related]
5. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
[TBL] [Abstract][Full Text] [Related]
6. Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study.
Hesselink MB; De Boer BG; Breimer DD; Danysz W
Pharm Res; 1999 May; 16(5):637-42. PubMed ID: 10350004
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats].
Gmiro VE; Serdiuk SE
Eksp Klin Farmakol; 2000; 63(2):16-20. PubMed ID: 10834088
[TBL] [Abstract][Full Text] [Related]
9. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
10. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.
Danysz W; Parsons CG; Kornhuber J; Schmidt WJ; Quack G
Neurosci Biobehav Rev; 1997 Jul; 21(4):455-68. PubMed ID: 9195603
[TBL] [Abstract][Full Text] [Related]
11. Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro.
Lupp A; Kerst S; Karge E; Quack G; Klinger W
Exp Toxicol Pathol; 1998 Sep; 50(4-6):501-6. PubMed ID: 9784030
[TBL] [Abstract][Full Text] [Related]
12. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Kornhuber J; Weller M; Schoppmeyer K; Riederer P
J Neural Transm Suppl; 1994; 43():91-104. PubMed ID: 7884411
[TBL] [Abstract][Full Text] [Related]
13. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study.
Spanagel R; Eilbacher B; Wilke R
Eur J Pharmacol; 1994 Sep; 262(1-2):21-6. PubMed ID: 7813574
[TBL] [Abstract][Full Text] [Related]
14. Memantine prevents progressive functional neurodegeneration in rats.
Heim C; Sontag KH
J Neural Transm Suppl; 1995; 46():117-30. PubMed ID: 8821047
[TBL] [Abstract][Full Text] [Related]
15. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
16. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.
Hesselink MB; Smolders H; Eilbacher B; De Boer AG; Breimer DD; Danysz W
J Pharmacol Exp Ther; 1999 Aug; 290(2):543-50. PubMed ID: 10411561
[TBL] [Abstract][Full Text] [Related]
17. Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.
Giorgetti M; Gibbons JA; Bernales S; Alfaro IE; Drieu La Rochelle C; Cremers T; Altar CA; Wronski R; Hutter-Paier B; Protter AA
J Pharmacol Exp Ther; 2010 Jun; 333(3):748-57. PubMed ID: 20194526
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine.
Peeters M; Romieu P; Maurice T; Su TP; Maloteaux JM; Hermans E
Eur J Neurosci; 2004 Apr; 19(8):2212-20. PubMed ID: 15090047
[TBL] [Abstract][Full Text] [Related]
19. Trapping channel block of NMDA-activated responses by amantadine and memantine.
Blanpied TA; Boeckman FA; Aizenman E; Johnson JW
J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
